Boron vs. Cancer
Biomedical researchers would like to be able to deliver chemicals directly to a cell nucleus-cancer therapy being one reason. UCLA chemist Fred Hawthorne may have discovered a chemical “roach motel” that provides entry to but no exit from the nucleus. He found the passageway while trying to get boron-rich compounds into cells in studies of a cancer treatment called boron neutron capture therapy (BNCT). In BNCT, boron atoms interact with neutron beams to create an unstable isotope that blows apart, as if the neutron had tripped a landmine inside the cell.
Hawthorne has designed novel, small molecules called nido-carboranyl oligomeric phosphate diesters-nido-OPDs-that carry boron into cell interiors more effectively than before. Although Hawthorne expected that the small nido-OPDs molecules would diffuse in and out of the nucleus, he found that they accumulated; once the molecules checked in, they didn’t check out. Most were still present in the nucleus 24 hours later, a finding that could help make BNCT a much more effective cancer treatment in the future.
Keep Reading
Most Popular
Large language models can do jaw-dropping things. But nobody knows exactly why.
And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Google DeepMind’s new generative model makes Super Mario–like games from scratch
Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.